Dan Suesskind Acquires 60,000 Shares of Nano-X Imaging (NASDAQ:NNOX) Stock

Nano-X Imaging Ltd. (NASDAQ:NNOX) Director Dan Suesskind bought 60,000 shares of the business’s stock in a transaction on Monday, September 14th. The stock was bought at an average price of $0.76 per share, for a total transaction of $45,600.00. Following the transaction, the director directly owned 110,000 shares of the company’s stock, valued at approximately $83,600. This represents a 120.00% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website.

Nano-X Imaging Stock Performance

NASDAQ NNOX opened at $0.70 on Tuesday. The firm’s fifty day moving average price is $0.95 and its two-hundred day moving average price is $1.65. The stock has a market cap of $55.01 million, a PE ratio of -0.33 and a beta of 1.26. Nano-X Imaging Ltd. has a fifty-two week low of $0.67 and a fifty-two week high of $4.71.

Nano-X Imaging (NASDAQ:NNOX) last announced its quarterly earnings results on Wednesday, September 9th. The company reported ($0.79) EPS for the quarter, missing analysts’ consensus estimates of ($0.16) by ($0.63). Nano-X Imaging had a negative net margin of 926.05% and a negative return on equity of 116.93%. The firm had revenue of $4.16 million during the quarter, compared to the consensus estimate of $5.38 million. As a group, sell-side analysts predict that Nano-X Imaging Ltd. will post -0.6 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently commented on NNOX shares. Alliance Global Partners lowered Nano-X Imaging from a “buy” rating to a “neutral” rating and cut their price target for the company from $5.00 to $3.00 in a research note on Tuesday, July 7th. Zacks Research raised Nano-X Imaging from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nano-X Imaging in a report on Wednesday, July 8th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $5.00 target price on shares of Nano-X Imaging in a research report on Monday, August 17th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $4.33.

Institutional Trading of Nano-X Imaging

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Aristides Capital LLC bought a new position in Nano-X Imaging during the 4th quarter worth $30,000. Independent Financial Group LLC bought a new stake in shares of Nano-X Imaging in the 1st quarter valued at about $26,000. Kestra Advisory Services LLC acquired a new stake in shares of Nano-X Imaging in the first quarter valued at about $26,000. Hsbc Holdings PLC acquired a new stake in shares of Nano-X Imaging in the first quarter valued at about $35,000. Finally, Engineers Gate Manager LP bought a new position in shares of Nano-X Imaging during the second quarter worth about $42,000. 21.49% of the stock is currently owned by institutional investors and hedge funds.

About Nano-X Imaging

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.